Matches 1 - 50 out of 87 1 2 >


Match Document Document Title
7122623 Compounds and methods for modulating cell adhesion  
Cyclic peptides comprising a cadherin cell adhesion recognition sequence HAV, and compositions comprising such cyclic peptides, are provided. Methods for using such peptides for modulating...
US20030224978 Compounds and methods for modulating apoptosis  
Cyclic peptides and compositions comprising such cyclic peptides are provided. The cyclic peptides comprise a classical cadherin cell adhesion recognition sequence HAV. Methods for using such...
US20030013655 Compounds and methods for regulating cell adhesion  
Methods for using modulating agents to enhance or inhibit cadherin-mediated cell adhesion in a variety of in vivo and in vitro contexts are provided. In particular, the modulating agents may be...
7476509 Compounds and methods for modulating functions of nonclassical cadherins  
Modulating agents and methods for enhancing or inhibiting nonclassical cadherin-mediated functions, such as atypical or desmosomal cadherin-mediated functions, are provided. The modulating agents...
8603986 Compounds and methods for modulating cadherin-mediated processes  
Peptides comprising a cadherin cell adhesion recognition (CAR) sequence, and compositions comprising such peptides, are provided. Methods of using such peptides for modulating cadherin-mediated...
US20030236186 Compounds and methods for inhibiting the interaction between alpha-catenin and beta-catenin  
Modulating agents for inhibiting an interaction between α-catenin and α-catenin are provided. The modulating agents comprise one or more of: (a) a β-catenin HAV motif; (b) a peptide analogue or...
US20050129676 Compounds and methods for modulating functions of classical cadherins  
Modulating agents and methods for enhancing or inhibiting classical cadherin-mediated functions are provided. The modulating agents comprise at least a tryptophan-containing cell adhesion...
6333307 Compounds and method for modulating neurite outgrowth  
Modulating agents comprising cyclic peptides, and compositions comprising such modulating agents are provided. The cyclic peptides comprise a cadherin cell adhesion recognition sequence HAV....
6203788 Compounds and methods for regulating cell adhesion  
Methods for using modulating agents to enhance or inhibit cadherin-mediated cell adhesion in a variety of in vivo and in vitro contexts are provided. In particular, the modulating agents may be...
6914044 Compounds and methods for modulating cell adhesion  
Cyclic peptides and compositions comprising such cyclic peptides are provided. The cyclic peptides comprise a cadherin cell adhesion recognition sequence HAV. Methods for using such peptides and...
7326686 Compounds and methods for regulating cell adhesion  
Methods for using modulating agents to enhance or inhibit cadherin-mediated cell adhesion in a variety of in vivo and in vitro contexts are provided. In particular, the modulating agents may be...
US20040132651 Compounds and methods for regulating cell adhesion  
Methods for using modulating agents to enhance or inhibit cadherin-mediated cell adhesion in a variety of in vivo and in vitro contexts are provided. In particular, the modulating agents may be...
US20030082166 Compounds and methods for modulating nonclassical cadherin-mediated functions  
Modulating agents for inhibiting or enhancing nonclassical cadherin mediated cell adhesion are provided. The modulating agents comprise one or more of: (a) a peptide sequence that is at least 50%...
US20120022083 SMALL MOLECULE MODULATORS OF CELL ADHESION  
Compounds, particularly compounds having activity as modulators of cadherin-mediated cell adhesion having the following structure: or a pharmaceutically acceptable salt, stereoisomer or prodrug...
6031072 Compounds and methods for modulating cell adhesion  
Cyclic peptides and compositions comprising such cyclic peptides are provided. The cyclic peptides comprise a cadherin cell adhesion recognition sequence HAV. Methods for using such peptides and...
6326352 Compounds and methods for modulating cell adhesion  
Cyclic peptides and compositions comprising such cyclic peptides are provided. The cyclic peptides comprise a cadherin cell adhesion recognition sequence HAV. Methods for using such peptides and...
6346512 Compounds and methods for modulating cell adhesion  
Cyclic peptides and compositions comprising such cyclic peptides are provided. The cyclic peptides comprise a cadherin cell adhesion recognition sequence HAV. Methods for using such peptides and...
6551994 Compounds and methods for inhibiting the interaction between α-catenin and β-catenin  
Modulating agents for inhibiting an interaction between α-catenin and β-catenin are provided. The modulating agents comprise one or more of: (a) a β-catenin HAV motif; (b) a peptide analogue or...
US20040175361 Compounds and methods for modulating functions of nonclassical cadherins  
Modulating agents and methods for enhancing or inhibiting nonclassical cadherin-mediated functions, such as atypical or desmosomal cadherin-mediated functions, are provided. The modulating agents...
7063842 Compounds and methods for inhibiting the interaction between α-catenin and β-catenin  
Modulating agents for inhibiting an interaction between α-catenin and β-catenin are provided. The modulating agents comprise one or more of: (a) a β-catenin HAV motif; (b) a peptide analogue or...
6207639 Compounds and methods for modulating neurite outgrowth  
Modulating agents comprising cyclic peptides, and compositions comprising such modulating agents are provided. The cyclic peptides comprise a cadherin cell adhesion recognition sequence HAV....
6358920 Compounds and methods for modulating nonclassical cadherin-mediated functions  
Modulating agents for inhibiting or enhancing nonclassical cadherin mediated cell adhesion are provided. The modulating agents comprise one or more of: (a) a peptide sequence that is at least 50%...
US20090291967 SMALL MOLECULE MODULATORS OF CELL ADHESION  
Compounds, particularly compounds having activity as modulators of cadherin-mediated cell adhesion having the following structure: or a pharmaceutically acceptable salt, stereoisomer or prodrug...
7138369 Compounds and methods for modulating apoptosis  
Cyclic peptides and compositions comprising such cyclic peptides are provided. The cyclic peptides comprise a classical cadherin cell adhesion recognition sequence HAV. Methods for using such...
6169071 Compounds and methods for modulating cell adhesion  
Cyclic peptides and compositions comprising such cyclic peptides are provided. The cyclic peptides comprise a cadherin cell adhesion recognition sequence HAV. Methods for using such peptides and...
6562786 Compounds and methods for modulating apoptosis  
Cyclic peptides and compositions comprising such cyclic peptides are provided. The cyclic peptides comprise a classical cadherin cell adhesion recognition sequence HAV. Methods for using such...
7456153 Compounds and methods for modulating functions of classical cadherins  
Modulating agents and methods for enhancing or inhibiting classical cadherin-mediated functions are provided. The modulating agents comprise at least a tryptophan-containing cell adhesion...
6683048 Compounds and methods for stimulating gene expression and cellular differentiation  
Modulating agents for inhibiting an interaction between α-catenin and β-catenin are provided. The modulating agents comprise one or more of: (a) a β-catenin HAV motif; (b) a peptide analogue or...
US20020151475 Compounds and methods for modulating cell adhesion  
Cyclic peptides and compositions comprising such cyclic peptides are provided. The cyclic peptides comprise a cadherin cell adhesion recognition sequence HAV. Methods for using such peptides and...
US20100240066 COMPOUNDS AND METHODS FOR MODULATING CADHERIN-MEDIATED PROCESSES  
Peptides comprising a cadherin cell adhesion recognition (CAR) sequence, and compositions comprising such peptides, are provided. Methods of using such peptides for modulating cadherin-mediated...
US20030229199 Compounds and methods for modulating nonclassical cadherin-mediated functions  
Modulating agents for inhibiting or enhancing nonclassical cadherin mediated cell adhesion are provided. The modulating agents comprise one or more of: (a) a peptide sequence that is at least 50%...
6465427 Compounds and methods for modulating cell adhesion  
Cyclic peptides comprising a cadherin cell adhesion recognition sequence HAV, and compositions comprising such cyclic peptides, are provided. Methods for using such peptides for modulating...
6806255 Compounds and methods for modulating adhesion molecule function  
Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV binding motif, an analogue or peptidomimetic...
6962969 Compounds and methods for modulating nonclassical cadherin-mediated functions  
Modulating agents for inhibiting or enhancing nonclassical cadherin mediated cell adhesion are provided. The modulating agents comprise one or more of: (a) a peptide sequence that is at least 50%...
6248864 Compounds and methods and modulating tissue permeability  
Methods for using modulating agents to enhance or inhibit occludin-mediated cell adhesion in a variety of in vivo and in vitro contexts are provided. Within certain embodiments, the modulating...
US20020193294 COMPOUNDS AND METHODS FOR MODULATING CLAUDIN-MEDIATED FUNCTIONS  
Methods for using modulating agents to enhance or inhibit claudin-mediated cell adhesion in a variety of in vivo and in vitro contexts are provided. Within certain embodiments, the modulating...
6391855 Compounds and methods for modulating junctional adhesion molecule-mediated functions  
Methods for using modulating agents to enhance or inhibit junctional adhesion molecule (JAM)-mediated cell adhesion in a variety of in vivo and in vitro contexts are provided. The modulating...
US20050163786 Compounds and methods for modulating adhesion molecule function  
Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV binding motif, an analogue or peptidomimetic...
6780845 Compounds and methods for cancer therapy  
Agents that inhibit the development of cancer and tumor growth are provided. Such agents comprise a classical cadherin CAR sequence HAV within a cyclic peptide ring, and may be used to prevent or...
6706685 Compounds and methods for stimulating β-catenin mediated gene expression and differentiation  
Modulating agents for inhibiting degradation of cytoplasmic β-catenin are provided. The modulating agents comprise one or more of: (1) the peptide sequence SYLDS(PO4)GIHS(PO4)G (SEQ ID NO:1) or...
6756356 Compounds and methods for modulating claudin-mediated functions  
Methods for using modulating agents to enhance or inhibit claudin-mediated cell adhesion in a variety of in vivo and in vitro contexts are provided. Within certain embodiments, the modulating...
6310177 Compounds and methods for modulating tissue permeability  
Methods for using modulating agents to enhance or inhibit occludin-mediated cell adhesion in a variety of in vivo and in vitro contexts are provided. Within certain embodiments, the modulating...
6303576 Compounds and methods for modulating β-catenin mediated gene expression  
Modulating agents for inhibiting β-catenin mediated gene expression are provided. The modulating agents comprise one or more of: (1) the peptide sequence LXXLL (SEQ ID NO:1); or (2) a peptide...
6723700 Compounds and methods for modulating claudin-mediated functions  
Method for using modulating agents to enhance or inhibit claudin-mediated cell adhesion in a variety of in vivo and in vitro contexts are provided. Within certain embodiments, the modulating...
6472368 Compounds and methods for modulating adhesion molecule function  
Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV binding motif, an analogue or peptidomimetic...
6830894 Compounds and methods for modulating claudin-mediated functions  
Methods for using modulating agents to enhance or inhibit claudin-mediated cell adhesion in a variety of in vivo and in vitro contexts are provided. Within certain embodiments, the modulating...
US20030109454 Compounds and methods for modulating adhesion molecule function  
Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV binding motif, an analogue or peptidomimetic...
US20030027761 Compounds and methods for modulating junctional adhesion molecule-mediated functions  
Methods for using modulating agents to enhance or inhibit junctional adhesion molecule (JAM)-mediated cell adhesion in a variety of in vivo and in vitro contexts are provided. The modulating...
6110747 Compounds and methods for modulating tissue permeability  
Methods for using modulating agents to enhance or inhibit occludin-mediated cell adhesion in a variety of in vivo and in vitro contexts are provided. Within certain embodiments, the modulating...
US20040106545 Compounds and methods for modulating cell adhesion  
Cyclic peptides comprising a cadherin cell adhesion recognition sequence HAV, and compositions comprising such cyclic peptides, are provided. Methods for using such peptides for modulating...

Matches 1 - 50 out of 87 1 2 >
« search again